We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+5.41%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.2B
AUM Growth
+$172M
(+0.43%)
Cap. Flow
-$1.31B
Cap. Flow
% of AUM
-3.26%
Top 10 Holdings %
Top 10 Hldgs %
18.88%
Holding
794
New
108
Increased
186
Reduced
363
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$427M |
| 2 |
RTN
Raytheon Company
RTN
|
+$193M |
| 3 |
RTX Corp
RTX
|
+$181M |
| 4 |
Marathon Petroleum
MPC
|
+$163M |
| 5 |
Deere & Co
DE
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$263M |
| 2 |
DuPont de Nemours
DD
|
+$238M |
| 3 |
Walmart Inc
WMT
|
+$216M |
| 4 |
Ross Stores
ROST
|
+$195M |
| 5 |
Fortive
FTV
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.26% |
| 2 | Technology | 15.21% |
| 3 | Financials | 12.82% |
| 4 | Consumer Discretionary | 11.4% |
| 5 | Industrials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Becton Dickinson
BDX
$46.4B
| $82.5M | 0.21% |
335,382
+65,314
| +24% | +$15.2M |
|
127
Ally Financial
ALLY
$13.1B
| $81.8M | 0.2% |
2,639,800
+899,800
| +52% | +$26.6M |
|
|
NVO
128
Novo Nordisk
NVO
$228B
| $81.7M | 0.2% |
3,200,000
+1,820,000
| +132% | +$45M |
|
|
ALXN
129
DELISTED
Alexion Pharmaceuticals
ALXN
| $81.1M | 0.2% |
619,462
+130,900
| +27% | +$16.9M |
|
130
CME Group
CME
$95.4B
| $80.5M | 0.2% |
414,731
-34,800
| -8% | -$6.42M |
|
131
TJX Companies
TJX
$179B
| $80.2M | 0.2% |
1,516,147
-1,423,126
| -48% | -$75.6M |
|
132
Nike
NKE
$64.1B
| $79.7M | 0.2% |
949,938
-128,900
| -12% | -$10.8M |
|
133
United Parcel Service
UPS
$88.9B
| $78.8M | 0.2% |
763,189
+184,789
| +32% | +$19.2M |
|
134
Stryker
SYK
$135B
| $77.8M | 0.19% |
378,597
-9,460
| -2% | -$1.81M |
|
135
Chubb
CB
$140B
| $77.4M | 0.19% |
525,424
-84,800
| -14% | -$12.2M |
|
|
KYNB
136
Kyntra Bio
KYNB
$27.4M
| $76.8M | 0.19% |
68,000
+26,000
| +62% | +$28.5M |
|
137
GE Aerospace
GE
$364B
| $76M | 0.19% |
+1,452,380
| New | +$71.5M |
|
138
Dentsply Sirona
XRAY
$2.84B
| $75M | 0.19% |
1,285,900
+209,600
| +19% | +$11.3M |
|
139
Colgate-Palmolive
CL
$74.8B
| $75M | 0.19% |
1,046,520
-33,800
| -3% | -$2.4M |
|
140
CF Industries
CF
$19.6B
| $74.4M | 0.19% |
+1,592,397
| New | +$69.1M |
|
141
Blackrock
BLK
$167B
| $74.1M | 0.18% |
157,880
-13,300
| -8% | -$6.02M |
|
142
Textron
TXT
$14.7B
| $74M | 0.18% |
1,395,902
+1,223,416
| +709% | +$62M |
|
143
Louisiana-Pacific
LPX
$5.14B
| $73.9M | 0.18% |
2,819,623
-650,000
| -19% | -$15.9M |
|
144
Citizens Financial Group
CFG
$30.1B
| $73.6M | 0.18% |
2,080,306
-302,094
| -13% | -$10.5M |
|
145
TE Connectivity
TEL
$60B
| $73.2M | 0.18% |
+764,634
| New | +$69M |
|
146
Sempra
SRE
$58.1B
| $73.2M | 0.18% |
1,065,600
+385,548
| +57% | +$25.3M |
|
147
CSX Corp
CSX
$94B
| $72.8M | 0.18% |
2,823,804
-83,100
| -3% | -$2.14M |
|
148
Cigna
CI
$78.4B
| $72.7M | 0.18% |
461,598
-14,700
| -3% | -$2.3M |
|
149
Equinix
EQIX
$99.4B
| $72.5M | 0.18% |
143,706
-38,000
| -21% | -$18.2M |
|
150
Fortune Brands Innovations
FBIN
$5.86B
| $70.4M | 0.18% |
1,441,575
-536,796
| -27% | -$23.9M |
|
Similar funds
Adage Capital Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Adage Capital Partners held 794 positions worth $40.2B, up 0.43% from $40B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Adage Capital Partners withdrew a net $1.31B in Q2 2019, closing 91 positions and reducing 363 holdings. Its most notable exit was InflaRx, an estimated $85.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Raytheon Company worth $186M.
- Adage Capital Partners's largest Q2 2019 buy was Raytheon Company: 1,071,108 shares worth $186M.
- Adage Capital Partners added most to Celgene Corp in Q2 2019, an estimated $427M increase.
- Adage Capital Partners's biggest Q2 2019 reduction was Honeywell, cutting an estimated $263M.
- Adage Capital Partners fully exited InflaRx in Q2 2019, selling an estimated $85.9M.
- Adage Capital Partners's ten largest holdings make up 19% of its $40.2B portfolio in Q2 2019.
- Adage Capital Partners opened 108 new positions and closed 91 in Q2 2019.
- Adage Capital Partners's portfolio value rose 0.43% quarter-over-quarter to $40.2B.
Based on Adage Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.